Bearish
Insulet Corporation (NASDAQ:PODD) has been downgraded to Neutral from Buy by Rothschild & Co Redburn, with a price target reduction from $380 to $220,...
Neutral
Medical device maker Insulet Corp. has requested a federal judge dismiss a proposed class action lawsuit challenging the performance of its 401(k) ret...
Bullish
Insulet Corp, with its Omnipod tubeless insulin delivery system, is a leader in the diabetes management market, appealing to both Type 1 and Type 2 pa...
Neutral
Moran Wealth Management LLC purchased a new stake in shares of Insulet Corporation (NASDAQ:PODD – Free Report) during the fourth quarter, according to...
Neutral
Short interest in Insulet Corporation (NASDAQ:PODD) increased by 19.3% in March, reaching 3,049,595 shares, representing 4.4% of shares outstanding. T...
This article mentions that analysts are projecting a significant 75% upside for Insulet Corporation (PODD) even though its share price momentum has be...